✦ LIBER ✦

Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis

✍ Scribed by Daniele Poole; Guido Bertolini; Silvio Garattini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of drotrecogin alfa (

✍ Aileen R Neilson; Hilmar Burchardi; Chris Chinn; Johannes Clouth; Heinz Schneide 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Evaluating the use of Drotrecogin alfa (

✍ Salmaan Kanji; Marc M. Perreault; Clarence Chant; David Williamson; Lisa Burry 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 199 KB

Cost effectiveness of drotrecogin alfa (

✍ A. Davies; S. Ridley; J. Hutton; C. Chinn; B. Barber; D. C. Angus 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

International integrated database for th

✍ Pierre-Francois Laterre; David R. Nelson; William Macias; Edward Abraham; Andrea 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 458 KB

International integrated database for th

✍ Dhainaut, Jean-François 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 484 KB

International INtegrated Database for th

✍ Sashegyi, Andreas; Trzaskoma, Benjamin L.; Nelson, David R.; Williams, Mark D.; 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 509 KB